About Matthew Wallington
Form D filings for Reperio Health from 2020 to 2024 list Matthew Wallington as executive officer and director.
Matthew Wallington first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Matthew Wallington in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthew Wallington works with at each company, as listed on that company's latest Form D.
Reperio Health, Inc. · Form D/A, Dec 27, 2024
PH
Philip Hertik
Director
TR
Travis Rush
Chief Executive Officer and director